Study: CAR T-Cell Therapy Highly Effective in High-Risk Chronic Lymphocytic Leukemia – AJMC.com Managed Markets Network
|
Study: CAR T-Cell Therapy Highly Effective in High-Risk Chronic Lymphocytic Leukemia
AJMC.com Managed Markets Network CD19 CAR T cells are highly effective in high-risk patients with chronic lymphocytic leukemia (CLL) who have failed to respond to treatment with ibrutinib, a Bruton's tyrosine kinase inhibitor, according to a study by Cameron J. Turtle, MD, and … |
